Quality management of biorepositories

Biopreservation and Biobanking

Volumn 13, Issue 3, 2015, Pages 183-194

  Grizzle, William E ^a,b   Gunter, Elaine W ^c   Sexton, Katherine C ^a   Bell, Walter C ^a,b  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b University of Alabama at Birmingham   (United States)

^c Specimen Solutions LLC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACCREDITATION; ANIMAL TISSUE; ARTICLE; BIOREPOSITORY; BODY FLUID; CERTIFICATION; ENVIRONMENTAL EXPOSURE; FREEZING; HEALTH CARE FACILITY; HUMAN; HUMAN TISSUE; LABORATORY; MEDICAL AUDIT; MEDICAL RESEARCH; NONHUMAN; OCCUPATIONAL EXPOSURE; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; QUALITY CONTROL; TOTAL QUALITY MANAGEMENT; BIOBANK; CLINICAL AUDIT; HEALTH CARE QUALITY; STANDARDS; STATISTICAL BIAS; TISSUE BANK;

ACCREDITATION; BIAS (EPIDEMIOLOGY); BIOLOGICAL SPECIMEN BANKS; BODY FLUIDS; CERTIFICATION; CLINICAL AUDIT; HUMANS; QUALITY ASSURANCE, HEALTH CARE; QUALITY CONTROL; TISSUE BANKS;

EID: 84930582743     PISSN: 19475535     EISSN: 19475543     Source Type: Journal    
DOI: 10.1089/bio.2014.0105     Document Type: Article

References (36)

1. Grizzle WE, Sexton KC, Bell WC. Quality assurance in tissue resources supporting biomedical research. Cell Preserv Technol 2008;6:113-118.
2. Centers for Disease Control and Prevention. Fourth Report on Human Exposure to Environmental Chemicals, 2009. Atlanta GA: US Department of Health and Human Services, Centers for Disease Control and Prevention. Available at http:// www.cdc.gov/exposurereport/pdf/fourthreport.pdf. Accessed 8 April 2015.
3. Gunter EW, McQuillan GM. Quality control in planning and operating the laboratory component of the Third National Health and Nutrition Examination Survey (NHANES III). J Nutr 1990;120:1451-1454.
4. Pirkle JL, Brody DJ, Gunter EW, et al. The decline in blood lead levels in the United States: The National Health and Nutrition Examination Surveys (NHANES). JAMA 1994;272: 284-291.
5. Gunter EW, Lewis BL, Konchikowski SM. Laboratory methods used for the Third National Health and Nutrition Examination Survey (NHANES III), 1988-1994. As contained in NHANES III Reference Manuals and Reports, NCHS CD-ROM, Centers for Disease Control and Prevention, Hyattsville, MD, October, 1996.
6. Bell WC, Sexton KC, Grizzle WE. Organizational issues in providing high-quality human tissues and clinical information for the support of biomedical research. Methods Mol Biol 2010;576:1-30.
7. Grizzle WE, Bell WC, Sexton KC. Issues in collecting, processing and storing human tissues and associated information to support biomedical research. In: Srivastava S, Grizzle WE, eds. Translational Pathology of Early Cancer, Amsterdam. IOS Press BV; 2012, pp. 531-549.
8. Grizzle WE, Sexton KC, Bell WC. Human tissue biorepository. In: Cheng L, Zhang D, Eble J, eds. Molecular Genetic Pathology. New York. Springer Science + Business Media 2013, pp. 483-497.
9. Ransohoff DF. Promises and limitations of biomarkers. Recent Results Cancer Res 2009;181:55-59.
10. Ransohoff DF. How to improve reliability and efficiency of research about molecular markers: Roles of phases, guidelines, and study design. J Clin Epidemiol 2007;60: 1205-1219.
11. Ransohoff DF. Bias as a threat to the validity of cancer molecular-marker research. Nat Rev Cancer 2005;5:142-149.
12. McLerran D, Grizzle WE, Feng Z, et al. Analytical validation of serum proteomic profiling for diagnosis of prostate cancer: Sources of sample bias. Clin Chem 2008;54: 44-52.
13. UK Biobank. Available at http://www.ukbiobank.ac.uk/. Accessed 8 April 2015.
14. Bell WC, Sexton KC, Grizzle WE. How to efficiently obtain human tissues to support specific biomedical research projects. Cancer Epidemiol Biomarkers Prev 2009;18: 1676-1679.
15. Grizzle WE, Srivastava S, Manne U. Translational pathology of neoplasia. In: Translational Pathology of Early Cancer. Eds. S Srivastava, WE Grizzle; IOS Press BV, Amsterdam, The Netherlands; 2012; pp. 7-20.
16. Henderson GE, Cadigan RJ, Edwards TP, et al. Characterizing biobank organizations in the US: Results from a national survey. Genome Med 2013;5:3.
17. Cadigan RJ, Lassiter D, Haldeman K, et al. Neglected ethical issues in biobank management: Results from a U.S. study. Life Sci Soc Pol 2013;9:1.
18. Potter DM, Butterfield LH, Divito SJ, et al. Pitfalls in retrospective analyses of biomarkers: A case study with metastatic melanoma patients. J Immunol Methods 2012;376: 108-112.
19. Prostate, Lung, Colon and Ovary Study (PLCO). Available at http://prevention.cancer.gov/plco/. Accessed 8 April 2015.
20. Hewitt RE, Grizzle WE, Watson PH, et al. Biobanking networks and global biobanking. In: Hainaut P, Vaught J, Pasterk M, Zatloukal K, eds. Biobanking of Human Specimens: Principle and Practice. New York Springer; in press.
21. Aamodt RL, Anouna A, Baird P, et al. Best practices for repositories I: Collection, storage and retrieval of human biological materials for research. Cell Preserv Technol 2005;3:5-48.
22. Pitt K, Campbell L, Skubitz A, et al. Best practices for repositories: Collection, storage, retrieval and distribution of biological materials for research. Cell Preserv Technol 2008;6:5-58.
23. Campbell L, Betsou F, Garcia DL, et al. Best practices for repositories: Collection, storage, retrieval, and distribution of biological materials for research. Biopreserv Biobank 2012;10:1-85.
24. Office of Biorepositories and Biospecimen Research, National Cancer Institute: Best Practices for Biospecimen Resources. Available at http://biospecimens.cancer.gov/ bestpractices/. Accessed 8 April 2015.
25. Canadian Tumour Repository Network (CTRNet). Available at https://www.ctrnet.ca. Accessed 8 April 2015.
26. International Organization for Standardization (ISO) - ISO 9001 and ISO 9001:2008. Available at http://www.iso.org/ iso/home/standards/management-standards/iso-9000.htm. Accessed 8 April 2015.
27. Federal Drug Administration's (FDA) Good Tissue Practices (GTP, 21 CFR, Part 1271). Available at http://www .fda.gov/. Accessed 8 April 2015.
28. Federal Drug Administration's Good Manufacturing Practices. Available at http://www.fda.gov. Accessed 8 April 2015.
29. International Air Transport Association (IATA). Available at http://www.ups.com/content/us/en/resources/ship/hazardous/ biological-substances.html. Accessed 8 April 2015.
30. United States Department of Transportation (DOT). Available at http://www.ncsu.edu/ehs/dot/Bio-shipping.pdf. Accessed 8 April 2015.
31. Steg A, Wang W, Blanquicett C, et al. Multiple gene expression analyses in paraffin-embedded tissues by Taqman low density array: Application to Hedgehog and Wnt pathway analysis in ovarian endometrioid adenocarcinoma. J Mol Diagn 2006;8:76-83.
32. Steg A, Vickers SM, Eloubeidi M, et al. Hedgehog pathway expression in heterogeneous pancreatic adenocarcinoma: Implications for the molecular analysis of clinically available biopsies. Diagn Mol Pathol 2007;16:229-237.
33. McNally LR, Manne U, Grizzle WE. Post-transcriptional processing of genetic information and its relation to cancer. Biotech Histochem 2013;88:365-372.
34. Tuck MK, Chan DW, Chia D, et al. Standard operating procedures for serum and plasma collection: Early Detection Research Network consensus statement. Standard Operating Procedure Integration Working Group. J Proteome Res 2009;8:113-117.
35. Wenk RE. Mechanism of interference by hemolysis immunoassays and requirements for sample quality. Clin Chem 1998;44:2554.
36. International Organization for Standardization. Available at http://www.iso.org/iso/home.html. Accessed 8 April 2015.